Fizazi K - Search Results

1

Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study.

Fizazi K, Oldenburg J, Dunant A, Chen I, Salvioni R, Hartmann JT, De Santis M, Daugaard G, Flechon A, de Giorgi U, Tjulandin S, Schmoll HJ, Bouzy J, Fossa SD, Fromont G. Fizazi K, et al. Ann Oncol. 2008 Feb;19(2):259-64. doi: 10.1093/annonc/mdm472. Epub 2007 Nov 27. Ann Oncol. 2008. PMID: 18042838 Free article.

2

Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy.

Soria JC, Fizazi K, Piron D, Kramar A, Gerbaulet A, Haie-Meder C, Perrin JL, Court B, Wibault P, Théodore C. Soria JC, et al. Among authors: fizazi k. Ann Oncol. 1997 Nov;8(11):1089-98. doi: 10.1023/a:1008248319036. Ann Oncol. 1997. PMID: 9426328 Free article.

3

Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy.

Fizazi K, Culine S, Droz JP, Kramar A, Théodore C, Ruffié P, Le Chevalier T. Fizazi K, et al. J Clin Oncol. 1998 Feb;16(2):725-32. doi: 10.1200/JCO.1998.16.2.725. J Clin Oncol. 1998. PMID: 9469363

4

Evaluation of estramustine phosphate combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Culine S, Kattan J, Zanetta S, Théodore C, Fizazi K, Droz JP. Culine S, et al. Among authors: fizazi k. Am J Clin Oncol. 1998 Oct;21(5):470-4. doi: 10.1097/00000421-199810000-00010. Am J Clin Oncol. 1998. PMID: 9781602 Clinical Trial.

5

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients.

Fizazi K, Dohollou N, Blay JY, Guérin S, Le Cesne A, André F, Pouillart P, Tursz T, Nguyen BB. Fizazi K, et al. J Clin Oncol. 1998 Dec;16(12):3736-43. doi: 10.1200/JCO.1998.16.12.3736. J Clin Oncol. 1998. PMID: 9850016

6

Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors.

Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Fizazi K, Einhorn L, Kanz L, Bokemeyer C. Hartmann JT, et al. Among authors: fizazi k. J Natl Cancer Inst. 2000 Jan 5;92(1):54-61. doi: 10.1093/jnci/92.1.54. J Natl Cancer Inst. 2000. PMID: 10620634

7

Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms.

Fizazi K, Zelek L. Fizazi K, et al. Ann Oncol. 2000 Feb;11(2):133-49. doi: 10.1023/a:1008344014518. Ann Oncol. 2000. PMID: 10761747 Free article. Review.

8

Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.

Fizazi K, Ducreux M, Ruffié P, Bonnay M, Daniel C, Soria JC, Hill C, Fandi A, Poterre M, Smith M, Armand JP. Fizazi K, et al. J Clin Oncol. 2000 Jun;18(11):2293-300. doi: 10.1200/JCO.2000.18.11.2293. J Clin Oncol. 2000. PMID: 10829050 Clinical Trial.

9

The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients.

André F, Fizazi K, Culine S, Droz J, Taupin P, Lhommé C, Terrier-Lacombe M, Théodore C. André F, et al. Among authors: fizazi k. Eur J Cancer. 2000 Jul;36(11):1389-94. doi: 10.1016/s0959-8049(00)00137-4. Eur J Cancer. 2000. PMID: 10899652

10

Peritoneal carcinomatosis in germ-cell tumor: relations with retroperitoneal lymph node dissection.

Andre F, Fizazi K, Culine S, Droz JP, Gatineau M, Takahashi Y, Oudard S, Theodore C. Andre F, et al. Among authors: fizazi k. Am J Clin Oncol. 2000 Oct;23(5):460-2. doi: 10.1097/00000421-200010000-00006. Am J Clin Oncol. 2000. PMID: 11039504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters